Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Amyloidosis × Blood Specimen Collection × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 46 Neoplasms 31 Colorectal Neoplasms 23 Melanoma 15 Prostatic Neoplasms 13 Neoplastic Cells, Circulating 12 Lung Neoplasms 12 Multiple Myeloma 11 Pancreatic Neoplasms 10 Ovarian Neoplasms 9 Uterine Cervical Neoplasms 8 Carcinoma, Non-Small-Cell Lung 8 Colonic Neoplasms 7 Papillomavirus Infections 6 Neoplasm Metastasis 6 Lymphoma 6 Leukemia, Myeloid, Acute 6 Hematologic Neoplasms 6 Uveal Melanoma 5 Head and Neck Neoplasms 5 Glioma 5 Sarcoma 4 Glioblastoma 4 Disease 4 COVID-19 4 Urinary Bladder Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasms, Plasma Cell 3

Interventions

Dexamethasone 10 Melphalan 7 Calcium Dobesilate 5 Lenalidomide 4 Bortezomib 4 miridesap 3 Cyclophosphamide 3 ixazomib 2 Doxycycline 2 dexamethasone acetate 1 dexamethasone 21-phosphate 1 carfilzomib 1 birtamimab 1 auricularum 1 Vinorelbine 1 Thalidomide 1 Tacrolimus 1 Pharmaceutical Preparations 1 Interleukin-2 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Gemcitabine 1 Filgrastim 1 Etanercept 1 Drug Evaluation 1 Blood Specimen Collection 1 Biopsy 1 Antilymphocyte Serum 1 ARQ 197 1 4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02716103 2021-09-10

MRD

Boston Medical Center

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡